The TresActio team have been accepted to the Novo Nordisk BioInnovation Institute, Business Acceleration academy!
Very happy to share that the TresActio team have secured grants from two separate Danish foundations, totaling 180,000 DKK. The funds will be used to cover costs of manufacturing of prototypes to be delivered for the first customer pilot in late March 2019.
Again thanks to the European Boost4Health initiative and the support of BioPeople here in Copenhagen, I will be taking part in this years BioFIT conference. I am looking forward to another great installment and the potential to promote current projects and customers. Please feel free to get in touch if you would like to meet up.
Thank you to DTU for this years High Tech Summit. It was a great opportunity to showcase the TresActio technology in multiple parallel events including the University Start-up World cup and the DTU HardTech Entrepreneurship course. We are eagerly awaiting to see how the many discussions we had over the course of the two days materialize.
I will be presenting ASPERISDx at next weeks TechBBQ. Please stop by the Health Tech Corner (Booths B9 to B16) to learn more.
TresActio will be showcasing at TechBBQ. I will update with more details shortly.
Having encountered two exciting opportunities, I have decided to dedicate 80% of my efforts to the projects TresActio and ASPERISDx (see Portfolio). TresActio, is an IoT company designing control systems for industrial fermentation systems where I am acting CFO and responsible for Business Development. ASPERISDx is a molecular diagnostics company focused on the industrial agriculture segment where I am acting CEO. I will be posting updates of major developments here.
I will remain open to interesting short term consulting projects so please feel free to reach out.
Very happy to share that the TresActio team I mentor as part of DTU’s Hardtech Course/Incubator has been selected as a Finalist to the 2018 edition of Denmarks Venture Cup. For more details on this edition please check out Venture Cup National Start-up Competition.
Our publication dealing with drug-binding dynamics has recently been published in the journal Biochemistry. The refined set of parameters, published in open access, will serve as an improved reference data set for the refinement of future molecular simulation.
I am very happy to be taking part as mentor in DTU’s Hardtech Entrepreneurship course/incubator. Working with patents from corporate sponsors, teams of young engineers are working on novel commercial applications and building the foundation for potential spin-outs/start-ups.
Thanks to the support of the European Boost4Health initiative, ASPERIS was able to participate in the 2017 edition of the BioFIT conference in Strasbourg. In particular, it was a great opportunity to meet with investors to hear investment priorities for 2018. Please follow the BioFIT link for further information on the 2018 edition.